Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-37,045
Closed -$1.88M 623
2017
Q3
$1.88M Buy
37,045
+305
+0.8% +$15.5K 0.01% 430
2017
Q2
$1.98M Sell
36,740
-907
-2% -$48.4K 0.01% 419
2017
Q1
$1.98M Sell
37,647
-6,947
-16% -$352K 0.01% 363
2016
Q4
$2.15M Buy
44,594
+8,828
+25% +$436K 0.01% 344
2016
Q3
$1.93M Buy
35,766
+16,548
+86% +$907K 0.01% 346
2016
Q2
$1.04M Buy
+19,218
New +$1.01M ﹤0.01% 391

Other funds holding GSK

AJO LP's GSK Position: Q4 2017 in Review

AJO LP sold out of GSK (GSK) in Q4 2017, closing a stake of 37,045 shares — an estimated $1.88M sold.

AJO LP first reported a position in GSK in Q2 2016 and held it in 6 quarters. The position peaked at $2.15M in Q4 2016. 763 funds tracked by Wall St. Rank hold GSK as of Q4 2017.

  • AJO LP reported no remaining GSK position as of Q4 2017 after selling out during the quarter.
  • AJO LP sold 37,045 GSK shares in Q4 2017, an estimated $1.88M.
  • AJO LP first reported a position in GSK in Q2 2016 and held it in 6 quarters.
  • AJO LP's GSK position peaked at $2.15M in Q4 2016.
  • 763 funds tracked by Wall St. Rank held GSK as of Q4 2017.

Based on AJO LP's 13F filing for Q4 2017, filed 14 Feb 2018.